astrocytes Archives • Fragile X Research

Integrating Human and Mouse Studies in Fragile X Syndrome – an NIH Center Approach

FRAXA Research Foundation Binder, Devin • Erickson, Craig • Huber, Kimberly • Pedapati, Ernest • Research Updates • Seminar Series December 23, 2020March 10, 2021astrocytes, EEG, glutamate, NIH, seizure

Presentations by:
Craig Erickson – Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome: A NIH Center Overview
Ernest Pedapati – Network Mechanisms, Biomarkers, and Pharmacology of Fragile X Syndrome in Humans
Devin Binder – Network Mechanisms of Neurophysiology and Behavior in mouse models of Fragile X Syndrome
Kimberly Huber – FMRP Regulation of local and long-range neocortical circuits in the mouse: Links with EEG phenotypes

Integrating Human and Mouse Studies in Fragile X Syndrome – an NIH Center Approach

FRAXA Research Foundation November 12, 2020April 15, 2021astrocytes, EEG, glutamate, hypersensitivity, NIH, seizure

A virtual seminar series focused on current topics in Fragile X research. This seminar features Craig A. Erickson, MD, Ernest Pedapati, MD, MS, FAAP, Devin K. Binder, MD, PhD, and Kimberly M. Huber, PhD presenting about an NIH Center approach to integrating human and mouse studies in Fragile X.

Mechanisms and Biomarkers of Sensory Hypersensitivity in the fmr1 Knockout Mouse

FRAXA Research Foundation Binder, Devin • Razak, Khaleel • Research Updates • Seminar Series August 27, 2020August 27, 2020astrocytes, DOD, drug repurposing, EEG, glutamate, Healx, hypersensitivity, matrix metalloproteinase, NIH, seizure, sound

In this Fragile X research webinar we hear from Devin K. Binder, MD, PhD, Professor, University of California at Riverside Medical School and Khaleel Razak, PhD, Professor, University of California at Riverside as they present about Mechanisms and Biomarkers of Sensory Hypersensitivity in the fmr1 Knockout Mouse.

Mechanisms and Biomarkers of Sensory Hypersensitivity in the fmr1 Knockout Mouse

FRAXA Research Foundation August 4, 2020April 15, 2021astrocytes, DOD, EEG, glutamate, hypersensitivity, matrix metalloproteinase, NIH, seizure, sound

This is the second in a series of webinars focused on current topics in Fragile X research. Devin K. Binder, MD, PhD, Professor, University of California at Riverside Medical School and Khaleel Razak, PhD, Professor, University of California at Riverside will present.

Cholesterol-Dependent Changes in Fragile X Astrocytes

FRAXA Research Foundation 2019 Grants • 2020 Grants • Castren, Maija • Current Research Grants • Disease Mechanisms • Drug Repurposing • Ethell, Iryna • University of California at Riverside • University of Helsinki Finland May 6, 2020June 1, 2020astrocytes, lovastatin

FRAXA Research Foundation has awarded $45,000 to Dr. Maija Castrén, of the University of Helsinki, Finland. Dr. Castren is working with Dr. Iryna Ethell, at the University of California at Riverside, to uncover mechanisms behind beneficial effects of lovastatin and cholesterol-dependent changes seen in the Fragile X brain.

MicroRNA Mediated Astroglial GLT1 Dysregulation in Fragile X

FRAXA Research Foundation 2017 Grants • 2018 Grants • Completed Research Grants • Disease Mechanisms • Higashimori, Haruki • Men, Yuqin • Treatment Targets • Tufts University • Yang, Yongjie September 30, 2017October 13, 2020astrocytes, autism, glutamate, Pierce Family Fragile X Foundation

Almost all brain research focuses on neurons – nerve cells. However, the brain has many more glial cells which support, nourish, and protect the neurons. FRAXA Research Foundation awarded a 2017 grant $90,000 to support Dr. Yang’s studies of how changes in glial cells contribute to Fragile X syndrome. This grant is funded by a grant from the Pierce Family Fragile X Foundation.

2017 Fragile X Research Grant: MicroRNA Mediated Astroglial GLT1 Dysregulation in Fragile X

Correcting Defects in Astrocyte Signaling in Fragile X Syndrome

FRAXA Research Foundation 2015 Grants • 2016 Grants • Disease Mechanisms • Doering, Laurie • McMaster University, Canada • Research Grant Results • Scott, Angela • Treatment Targets September 14, 2016February 25, 2020astrocytes, NIH

With a $90,000 grant from the FRAXA Research Foundation from 2015-2016, Dr. Laurie Doering and Dr. Angela Scott at McMasters University studied astrocytes in Fragile X. Astrocytes, brain cells which support neurons, do not transmit signals. Several treatment strategies for Fragile X have been proposed based on correction of “astrocyte phenotypes”.

Fragile X Treatment: New Research Directions

Michael Tranfaglia, MD Research Updates March 12, 2015December 26, 2019astrocytes, BK channel, glutamate, hyperexcitability, ion channel, mGluR, mGluR5, NIH, seizure, sound

In the wake of negative results from several high-profile clinical trials in Fragile X, we find ourselves questioning many of our previous assumptions about the nature of this disorder. After all, understanding the basic pathology of disease is critical to development of new treatments — this is true across the board, in all branches of medicine.

Glutamate Metabolism in Fragile X Mouse Brain

FRAXA Research Foundation 2006-2010 Grants • Completed Research Grants • Disease Mechanisms • McKenna, Mary • Treatment Targets • University of Maryland February 15, 2008April 28, 2018astrocytes, GABA, glutamate, mGluR, mGluR5

With a $95,000 grant from FRAXA Research Foundation over 2 years, Mary McKenna at the University of Maryland studied the role of metabotropic glutamate receptors (mGluR) and how they affect other cells and pathways.